Home » Topics » BioWorld Science

BioWorld Science
RSS

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Oct. 25, 1996

No Comments

Efficacy of Ampligen demonstrated in chronic fatigue syndrome

Oct. 25, 1996

No Comments

Clinical trials with Bradycor suspended pending clarification of anomalous animal findings

Oct. 25, 1996

No Comments

NS-1201 available for licensing

Oct. 25, 1996

No Comments

Daiichi reports calmodulin inhibitors

Oct. 25, 1996

No Comments

SCRAS claims NOS inhibitors

Oct. 25, 1996

No Comments

Glaxo Wellcome claims NMDA antagonists

Oct. 25, 1996

No Comments

Twenty-four drugs in development for Alzheimer's disease in U.S.

Oct. 25, 1996

No Comments

Two Alzheimer's drugs in phase III in Japan

Oct. 25, 1996

No Comments

Spotlight on ALS research

Oct. 25, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

BioWorld Science
RSS

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Efficacy of Ampligen demonstrated in chronic fatigue syndrome

Clinical trials with Bradycor suspended pending clarification of anomalous animal findings

NS-1201 available for licensing

Daiichi reports calmodulin inhibitors

SCRAS claims NOS inhibitors

Glaxo Wellcome claims NMDA antagonists

Twenty-four drugs in development for Alzheimer's disease in U.S.

Two Alzheimer's drugs in phase III in Japan

Spotlight on ALS research

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

BioWorld Science RSS

BioWorld Science
RSS